指南与共识介入妇产影像泌尿生殖DSAMRUS

症状性子宫腺肌病的子宫动脉栓塞治疗:介入放射学会基金会研究共识专家组的会议纪要

Uterine Artery Embolization for Symptomatic Adenomyosis: Proceedings from a Society of Interventional Radiology Foundation Research Consensus Panel.
指南 / 共识 · J Vasc Interv Radiol · 2022-01-01

介入放射学会基金会召集多学科研究共识专家组,围绕子宫腺肌病的临床表现与影像诊断、现有药物/介入/手术治疗选择及子宫动脉栓塞治疗症状性疾病的文献与经验进行讨论;专家组认为开展临床试验前需先评估腺肌病影像标准并与病理和症状关联以建立无创影像分类系统,其次制定生活质量问卷,第三开展比较子宫动脉栓塞与药物治疗的前瞻性临床试验。

要点

  • 腺肌病因临床表现和影像表现多样且常与其他良性妇科疾病共存,诊断和治疗均具挑战。
  • 近年子宫动脉栓塞治疗腺肌病显示出令人鼓舞的良好结局和长期症状改善。
  • 专家组将建立腺肌病无创影像分类系统列为开展临床试验前的首要任务。

核心结论

  • 专家组认为开展临床试验前必须先评估腺肌病的影像标准,并将其与病理和症状相关联,以建立无创影像分类系统。
  • 第二优先事项是制定生活质量问卷以评估治疗后的患者结局。
  • 第三优先事项是开展比较子宫动脉栓塞与药物治疗的前瞻性临床试验,以帮助将子宫动脉栓塞确立于症状性腺肌病的治疗流程和学会指南中。

研究设计与样本

  • 介入放射学会基金会召集的多学科研究共识专家组,专家来自不同背景。
  • 讨论主题围绕腺肌病的临床表现与影像诊断、现有药物/介入/手术治疗选择,以及子宫动脉栓塞治疗症状性疾病的现有文献与经验。

诊断标准与关键数值

  • 专家组认为需先评估腺肌病的影像诊断标准并与病理和症状相关联,以建立无创影像分类系统,原文未给出具体影像标准或数值。

临床应用与阅片要点

  • 专家组将评估腺肌病影像标准并与病理和症状关联以建立无创影像分类系统列为开展临床试验前的首要任务。
  • 专家组将制定评估治疗后患者结局的生活质量问卷列为第二优先事项。
  • 专家组将开展比较子宫动脉栓塞与药物治疗的前瞻性临床试验列为第三优先事项,以帮助将子宫动脉栓塞确立于症状性腺肌病的治疗流程和学会指南中。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Adenomyosis poses an important diagnostic and therapeutic challenge in women's health because of a variety of clinical/imaging presentations and frequent coexistence with other benign gynecologic conditions. In recent years, uterine artery embolization (UAE) for the treatment of adenomyosis has shown encouraging and favorable outcomes and long-term symptom improvement. To expand the current understanding of adenomyosis pathophysiology, imaging diagnostic criteria, and treatment outcomes, the Society of Interventional Radiology Foundation gathered a multidisciplinary Research Consensus Panel with experts from diverse backgrounds. The topics addressed were centered around the following: (i) the clinical presentation and imaging findings to diagnose adenomyosis; (ii) the currently available medical, interventional, and surgical treatment options; and (iii) existing literature for and experiences with UAE in symptomatic disease. The panel acknowledged that before the pursuit of a clinical trial, it would be necessary to first evaluate the imaging criteria for adenomyosis and correlate them with pathology and symptoms to establish a noninvasive imaging classification system. Second priority was given to the development of a quality of life questionnaire to assess patient outcomes following treatment. The third priority was the performance of a prospective clinical trial comparing UAE with medical therapy, which would help establish UAE in the treatment algorithm and societal guidelines for symptomatic adenomyosis.

来源:J Vasc Interv Radiol,查看原文。版权归原作者所有。

引用

  1. Caridi TM, De la Garza-Ramos C, Brook OR, et al. Uterine Artery Embolization for Symptomatic Adenomyosis: Proceedings from a Society of Interventional Radiology Foundation Research Consensus Panel. J Vasc Interv Radiol. 2022. PMID: 35489788. doi:10.1016/j.jvir.2022.01.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。